Publications by authors named "Van Tompkins"

Claim this Profile
I
Identification of a conserved RNA structure in the 3'UTR: Implications for post-transcriptional regulation.
Van S Tompkins, Warren B Rouse, Jibo Wang, Michael E Woodman, Ernst R Dow

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RNA secondary structure of androgen receptor-FL and V7 transcripts reveals novel regulatory regions.
Warren B Rouse, Van S Tompkins, Collin A O'Leary, Walter N Moss

Nucleic Acids Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of MYC intron 2 regions that modulate expression.
Van S Tompkins, Zheng Xue, Jake M Peterson, Warren B Rouse, Collin A O'Leary

PLoS One· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of RNA secondary structural motifs using sequence-ordered thermodynamic stability and comparative sequence analysis.
Jake M Peterson, Collin A O'Leary, Evelyn C Coppenbarger, Van S Tompkins, Walter N Moss

MethodsX· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermodynamic and structural characterization of an EBV infected B-cell lymphoma transcriptome.
Collin A O'Leary, S Van Tompkins, Warren B Rouse, Gijong Nam, Walter N Moss

NAR Genom Bioinform· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of human cancer driver genes uncovers evolutionarily conserved RNA structural elements involved in posttranscriptional control.
Van S Tompkins, Warren B Rouse, Collin A O'Leary, Ryan J Andrews, Walter N Moss

PLoS One· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A map of the SARS-CoV-2 RNA structurome.
Ryan J Andrews, Collin A O'Leary, Van S Tompkins, Jake M Peterson, Hafeez S Haniff

NAR Genom Bioinform· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs.
Lumbini I Moss, Van S Tompkins, Walter N Moss

Noncoding RNA Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA structural analysis of the MYC mRNA reveals conserved motifs that affect gene expression.
Collin A O'Leary, Ryan J Andrews, Van S Tompkins, Jonathan L Chen, Jessica L Childs-Disney

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.
Minjie Gao, Bo Li, Xi Sun, Yunfei Zhou, Yingcong Wang, Van S Tompkins

Theranostics· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIAS1 Promotes Lymphomagenesis through MYC Upregulation.
Andrea Rabellino, Margherita Melegari, Van S Tompkins, Weina Chen, Brian G Van Ness

Cell Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus deferred treatment for smoldering multiple myeloma: a meta-analysis of randomized, controlled trials.
Minjie Gao, Guang Yang, Van S Tompkins, Lu Gao, Xiaosong Wu

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas.
Sara M Reed, Jussara Hagen, Viviane P Muniz, Timothy R Rosean, Nick Borcherding, Van S Tompkins

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53.
Sara M Reed, Jussara Hagen, Van S Tompkins, Katie Thies, Frederick W Quelle

Cell Cycle· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide after stem-cell transplantation for multiple myeloma: a meta-analysis of randomized controlled trials.
Minjie Gao, Lu Gao, Guang Yang, Yi Tao, Van S Tompkins

Int J Clin Exp Pathol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
Seong-Su Han, Van S Tompkins, Dong-Ju Son, Sangwoo Han, Hwakyung Yun

Exp Hematol Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts.
Xuefeng Zhang, Jussara Hagen, Viviane P Muniz, Tarik Smith, Gary S Coombs, Van S Tompkins

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells.
Jaimee C Eckers, Amanda L Kalen, Ehab H Sarsour, Van S Tompkins, Siegfried Janz

Radiat Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
Timothy R Rosean, Van S Tompkins, Guido Tricot, Carol J Holman, Alicia K Olivier

Immunol Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of candidate B-lymphoma genes by cross-species gene expression profiling.
Van S Tompkins, Seong-Su Han, Alicia Olivier, Sergei Syrbu, Thomas Bair

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells.
Minjie Gao, Lu Gao, Yi Tao, Jun Hou, Guang Yang, Van S Tompkins

Acta Biochim Biophys Sin (Shanghai)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.
Seong-Su Han, Van S Tompkins, Dong-Ju Son, Natalie L Kamberos, Laura L Stunz

Biochem Biophys Res Commun· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients.
Viviane P Muniz, Ryan W Askeland, Xuefeng Zhang, Sara M Reed, Van S Tompkins

Genes Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.
Jan Suthaus, Christiane Stuhlmann-Laeisz, Van S Tompkins, Timothy R Rosean, Wolfram Klapper

Blood· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Seong-Su Han, Hwakyung Yun, Dong-Ju Son, Van S Tompkins, Liangping Peng

Mol Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis